CA21967-2A - 0x0000000000003102

Study Number: CA21967
Group Number: 2A
Study Requirement: Healthy Normal Male
Stipend: up to £ 1,000

Study Criteria:

  • Age: 18 - 50
  • BMI: 0 - 0
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat Cystic Fibrosis.
  • Route of Administration: Inhalation
  • Blood Draws: 10

Study Schedule:

  • Schedule Type: Short Term
  • Study Length: One - 2 Night Stay, 1 Return & 2 Phone Calls

Screening Dates:

Event Day Event Date Site
Wednesday Oct 25 2017 Belfast

Doctor Exam Dates:

Event Day Event Date Site
Wednesday Oct 25 2017 Belfast
Thursday Oct 26 2017 Belfast

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Sunday Nov 5 2017 1:00PM Tuesday Nov 7 2017 5:30PM 1 Belfast
Phone participant* Thursday Nov 9 2017 9:00AM 1 Belfast
Phone participant* Saturday Nov 11 2017 9:00AM 1 Belfast
Return Monday Nov 13 2017 8:00AM Monday Nov 13 2017 11:30AM 1 Belfast